All In MedTech

Company

Medacta

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Medacta, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Medacta.

Latest FDA decisions

The 8 newest of 160 since 2015.

Search the Clearance Tracker

157 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT02748408 · 550 participants (planned) · Start Jul 2015 · Primary completion Jul 2032

    Device: SMS femoral stem · For: Arthrosis; Traumatic Arthritis; Rheumatoid Polyarthritis and 2 more

    Sites: Vienna, Austria; Milan, Italy; Solothurn, Switzerland · 4 sites in all

  • NCT05460715 · 300 participants (planned) · Start Jul 30, 2021 · Primary completion Jul 2032

    Device: Quadra P anteverted · For: Arthrosis; Traumatic Arthritis; Rheumatoid Polyarthritis and 2 more

    Sites: Messina, Italy

  • NCT06748885 · 88 participants (planned) · Start Feb 28, 2024 · Primary completion Dec 2030

    Device: Mpact 3D Metal Monolith · For: Total Hip Arthroplasty (THA)

    Sites: Nantes, France; Paris, France · 3 sites in all

40 more trials with a free account

Reports received

1,399

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

90

6.4% of reports

Injury reports

1,308

93% of reports

Death reports

1

0.1% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 23412200
Jan 2438400
Feb 2435800
Mar 2438100
Apr 24109400
May 2479900
Jun 24310100
Jul 24210500
Aug 24310200
Sep 2488300
Oct 24911300
Nov 2479200
Dec 24312000
Jan 2546800
Feb 25311400
Mar 25179500
Apr 25510400
May 25413300
Jun 2589100
Jul 251313200
Aug 2557600
Sep 25210310
Oct 25711200
Nov 251114100
Dec 25113300
Jan 2666410
Feb 2637500
Mar 26712500
Apr 2638900
May 261015000
Jun 26106700
Jul 261516800
Aug 2667700
Sep 2676800
Oct 261115100
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

20 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.